Previous Article | Next Article ![]()
J. Virol., Jun 1996, 4167-4172, Vol 70, No. 6
J Pak and DV Faller
Nonacutely transforming retroviruses, such as Moloney murine leukemia virus
(M-MuLV), differ from transforming viruses in their mechanisms of tumor
induction. While the transforming viruses cause tumors by transduction of
oncogenes, the leukemia retroviruses, lacking oncogenes, employ other
mechanisms, including promoter insertion and enhancer activation. Although
these two mechanisms occur in many tumors induced by leukemia viruses, a
substantial proportion of such tumors do not show site-specific proviral
insertions. Thus, other, unidentified virus-driven mechanisms may
participate in tumorigenesis. In these studies, we show that infection of
cells by M-MuLV activates expression of Rel family transcription factors.
In murine cells chronically infected with M-MuLV, gel shift analyses with
kappaB DNA-binding motifs from the murine immunoglobulin kappa light chain
enhancer demonstrated induction of at least two distinct kappaB
enhancer-binding complexes. Supershifting and immunoblotting analyses
defined p50, p52, RelB, and c- Rel subunits as constituents of these
virus-induced protein complexes. Transient transfections performed with
kappaB-dependent reporter plasmids showed transcriptional activation in
M-MuLV-infected cells relative to uninfected cells. Induction of
Rel/NF-kappaB transcription factor activity by M-MuLV infection may prove
relevant to the mechanism of M-MuLV-induced leukemia.
Copyright © 1996, American Society for Microbiology
Moloney murine leukemia virus activates NF-kappa B
Department of Pathology and Laboratory Medicine, Cancer Research Center, Boston University School of Medicine, Massachusetts 02118, USA.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|